According to Coherent Market Insights, Global DNA Sequencing Market is estimated to be valued at US$ 6,802.2 million in 2023 and is expected to exhibit a CAGR
Global Precision Medicine Market, By
Technology (Bioinformatics, Drug Discovery, Gene Sequencing, Precision Molecular Diagnostics, and Big Data Analytics), By Application (Oncology, CNS, Respiratory, Immunology, Hematology, and Others),
and
By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Trends, Analysis and Forecast till 2030.”
Key Highlights:
In January 2018, Syapse collaborated with Roche in order to advance precision medicine in oncology. Also, this partnership focuses on clinical delivery and product development for introducing precision medicine to more patients.
In March 2018, DSM partnered with Mixfit to provide personalized nutrition solutions by combining Artificial Intelligence (AI) technology.
Analyst View:
Growing demand and advancements in cancer biology will drive personalized medicine market during the forecast period. Accessibility to large-scale human genome database including next-generation sequencing